Company Active LTD

Company profile

Morgan Innovation & Technology Ltd

Morgan Innovation & Technology. Making a Difference in Tomorrows World.

Morgan Innovation & Technology - Designing, Developing and Manufacturing Tomorrow's Innovations in Medical and Commercial Industries.

CRN
02174066
Founded
1987
Age
38

Overview

Legal name
MORGAN INNOVATION & TECHNOLOGY LTD
Region
South East England
Registered address
UNIT 17
PETERSFIELD BUSINESS PARK, BEDFORD ROAD
PETERSFIELD
HAMPSHIRE
GU32 3QA
Insolvency history
Yes

Corporate ownership

Updated 06 Jun 2026 16:52

Morgan Innovation & Technology Ltd
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

7 events
20 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

06 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

19 Feb
2025

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ1NTY4ODg5NmFkaXF6a2N4

Published 19 Feb 2025 02:06

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

23 Sep
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzNjg4MDc5MWFkaXF6a2N4

Published 23 Sep 2024 06:53

06 Oct
1987

Incorporated

Inception

Company registered at Companies House

Public funding

7 awards
First funded
2013
Funded years
2013, 2014, 2018, 2020, 2023
Age at first award
25 years

Projects

2023 Collaborative R&D Lead participant

Salurate - Validation of salivary uric monitoring for early prediction of hypertensive disorders in pregnancy

1 Jun 2023 to 31 May 2026

Awarded
£992,937
Total cost £1,418,481

Over 10% of pregnant women experience high blood pressure (hypertension) and related conditions such as pre-eclampsia (PE). Untreated PE is the second biggest cause of maternal deaths - 63,000 annually worldwide, but despite this, there is no way of accurately predicting who may develop PE. This causes anxiety for expectant mothers and puts them and their...

2020 Study Lead participant

Grace - Health Technology for a safe and effective solution to menopausal hot flushes and night sweats

1 Jan 2020 to 30 Apr 2021

Awarded
£157,829
Total cost £225,470

Around 300,000 women start experiencing hot flushes every year in the UK. They are uncomfortable, embarrassing and above all inconvenient, striking any time - day and night. Choosing a solution can be confusing and difficult. Those days could soon be gone. Enter Grace (product name), the world's first automated tracking and cooling bracelet, ready to dete...

2018 Feasibility Studies Lead participant

MISTRAL - An innovative system for high-precision delivery of gas/air mixture in eye surgery

1 Apr 2018 to 31 Dec 2018

Awarded
£97,133
Total cost £138,761

"We aim to create an innovative device for use in vitreoretinal surgery (operations to treat sight-threatening eye disorders involving the retina, macula, and vitreous fluid). The opportunity is that the mixing and introduction of a gas/air mix during vitreoretinal surgery using current devices is imprecise, subject to human error, and its critical parame...

2014 GRD Proof of Concept Lead participant

Morgan-IAT: Haptic Sensory System for the Hand

1 May 2014 to 31 Oct 2015

Awarded
£100,000
Total cost £178,600

Haptic technology, or haptics, is a feedback technology, which mimics the sense of touch by applying stimuli, such as compression, friction & vibration forces to the user. In gaming & in "sensory rehabilitation" for individuals with disability, the ability for a user to 'feel' a virtual environment as well as ‘see’ it would be a significant advance on wha...

2014 GRD Proof of Market Lead participant

Morgan Innovation & Technology Ltd Study to examine the feasibility of establishing a Tele-Health Testing Service for pre eclampsia in ante-natal care

1 Jan 2014 to 31 Oct 2014

Awarded
£24,998
Total cost £46,963

There is currently a clinical study being undertaken in 6 hospitals of up to 1000 women for Salurate a predictive device which tests for the condition known as pre-eclampsia which can occur during pregnancy. The clinical study is to confirm the results of a Pilot Study carried out at one of the hospitals and is partly funded by a TSB Grant. The grant also...

2013 GRD Proof of Market Lead participant

Saline Infusion Pump Monitoring & Alarm System (SIPMAS)

1 Apr 2013 to 31 Dec 2013

Awarded
£25,000
Total cost £46,249

Intra-arterial catheters are used to introduce fluids, such as drugs, into or take blood samples from patients. The catheter itself is a small plastic tube with connectors. The plastic tube is inserted into the artery and the connectors lie on the outside of the patients’ body making introducing fluids or taking samples straightforward and painless. Intra...

2013 GRD Development of Prototype Lead participant

Predictive Test for Pre Eclampsia (PTPE)

1 Jan 2013 to 30 Jun 2015

Awarded
£243,230
Total cost £540,513

Pre-ecampsia (PE) is a syndrome that is a major cause of morbidity and mortality in mothers and babies. Current indicators have limited reliability, an apparently-well woman throughout pregnancy may suddenly develop PE symptoms close to term, with potentially catastrophic consequences. There have been many studies, in 2008 Khan et al reviewed over 1700 re...

Product types

Collaborative R&D Feasibility Studies GRD Development of Prototype GRD Proof of Concept GRD Proof of Market Study